Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-24-110179
Filing Date
2024-09-30
Accepted
2024-09-30 09:13:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 pro_sup_september_2024.htm 424B5 15262
2 GRAPHIC img236605585_0.jpg GRAPHIC 20593
  Complete submission text file 0000950170-24-110179.txt   44951
Mailing Address BIOCITY GLASGOW BO'NESS ROAD, NEWHOUSE LANARKSHIRE X0 ML1 5UH
Business Address BIOCITY GLASGOW BO'NESS ROAD, NEWHOUSE LANARKSHIRE X0 ML1 5UH 44 020 7788 7414
Virax Biolabs Group Ltd (Filer) CIK: 0001885827 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: 424B5 | Act: 33 | File No.: 333-275893 | Film No.: 241336959
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)